🔗 Share this article

An senior health official has been taken off from participation in a key research project into gender-affirming medication subsequent to allegations regarding preconceived views came to light.

Reported Involvement Led to Study Pause

As reported by news coverage, Prof Jacob George, the chief medical and scientific officer at the regulatory agency, voiced issues that caused the pausing of a national Pathways trial during February.

This regulator stated this weekend that George had recused himself from involvement with the study once questioning social media comments posted in the past were identified.

Nature of Online Comments

Among one comment, George referred to author the Harry Potter author being a valuable figure in modern society.” In another, he stated that the refusal to accept basic scientific reality is worrisome” regarding discussions about a Olympic athlete’s gender.

The agency clarified that even though George’s posts were posted before his appointment, the official was removed of oversight with the trial as a abundance of caution.

Particulars of the Paused Pathways Study

The research project, that aimed to study the influence of hormone suppressants on children exploring their gender identity, was due to begin enrolling participants during the start of the year.

However, it was paused in February when its agency expressed apprehensions over the welfare of children and young people involved.

• The most junior subjects were expected to start at ten to eleven for biological females while 11 to 12 among biological males.
• The trial organizers stated at the time that the strict screening process suggested those enrolled would probably be older.
• But, the regulator has now stated the minimum age requirement ought to be 14 because of an uncertain potential” of “long-term health consequences.”

This clinical trial aimed to enroll around 226 young people during the following several years.

Background and a Cass Review

This trial was commissioned subsequent to an urging from a major report on youth gender care, that concluded that the standard of the research claiming to demonstrate the benefits of such treatment for children with gender incongruence were weak.”

Doctor Hilary Cass, who led that review, has previously said her report revealed an extremely poor scientific foundation” for the benefits of such treatments.

She continued, “given that there are doctors, young people and parents who are convinced deeply in the helpful results, a study remained the sole method forward to understand the situation.”

Medical Criticism of the Decision

Doctor Max Davie, a consultant paediatrician, stated there existed no convincing evidence-based justification to halt the research.

“The tweets from Prof George offer a transparent view of his personal views on the topic,” he said. “He is quite at liberty to have whatever views about gender identity he wishes, but what he cannot do is allow these beliefs to impact the performance of his public duty.”

The doctor added: “It must be understood, there exists no compelling scientific reason to pause this study. While Prof George’s individual beliefs are not the only potential reason of the MHRA’s unexpected volte-face, it is the single factor for which we have supporting information.”

Regulator Response and Next Steps

A regulatory spokesperson commented: “With all medical studies, our primary concern is the safety and wellbeing for the trial participants. As part of that promise, detailed studies remain continuously under scrutiny while the MHRA maintains an ongoing discussion with research organizers.”

“We has expert scientific, medical and oversight professionals who function in a cross-functional team to deliver scientifically sound judgments regarding medical research. These individuals are continuing to engage alongside the university to address the next steps constructively.”

“Subsequent to the finding regarding social media posts posted before his appointment, Prof Jacob George was recused of any additional oversight with the Pathways study as an preventative step.”